Steiner, L., Bermudez, L. S., Ghazal, M., Abba, M., Gerhards, C., Metzgeroth, G., Fabarius, A., Klein, S., Kreil, S., Schmitt, N., Hofmann, W., Streuer, A. (2025). Dose-adjusted treatment with venetoclax for 7 days and 5-azacitidine or decitabine in patients with Acute Myeloid Leukemia or higher risk myelodysplastic neoplasms. Blood. https://doi.org/10.1182/blood-2025-1622